Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Davignon

Showing results (221-230 of 236) with videos related to

Pageof 24
Sort By:
Human Biology|February 1, 1993
Genealogy and regional distribution of lipoprotein lipase deficiency in French-Canadians of QuebecC Dionne, C Gagné, P Julien, et al.
Neurobiology of Disease|February 15, 2000
Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brainC Ramassamy, D Averill, U Beffert, et al.
Atherosclerosis|August 1, 1995
Long-term efficacy and tolerability of simvastatin in a large cohort of elderly hypercholesterolemic patientsP J Lansberg, Y B Mitchel, D Shapiro, et al.
Annales De Genetique|January 1, 1992
Genetic epidemiology of lipoprotein lipase deficiency in Saguenay-Lac-St-Jean (Québec, Canada)C Dionne, C Gagné, P Julien, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 11, 1992
In vivo metabolism of apolipoprotein A-I in a patient with homozygous familial hypercholesterolemiaJ R Schaefer, D J Rader, K Ikewaki, et al.
The American Journal of Cardiology|February 15, 1994
Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemiaJ Davignon, G Roederer, M Montigny, et al.
Free Radical Biology & Medicine|September 18, 1999
Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotypeC Ramassamy, D Averill, U Beffert, et al.
Journal of Internal Medicine|February 20, 2007
Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic toolsS M Marcovina, F Crea, J Davignon, et al.
The Journal of Clinical Investigation|March 1, 1995
The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humansD J Rader, W A Mann, W Cain, et al.
Atherosclerosis|June 28, 2001
Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemiaW Insull, M Koren, J Davignon, et al.
Pageof 24

Showing results (221-230 of 236) with videos related to

Sort By:
Pageof 24
Human Biology|February 1, 1993
Genealogy and regional distribution of lipoprotein lipase deficiency in French-Canadians of QuebecC Dionne, C Gagné, P Julien, et al.
Neurobiology of Disease|February 15, 2000
Oxidative insults are associated with apolipoprotein E genotype in Alzheimer's disease brainC Ramassamy, D Averill, U Beffert, et al.
Atherosclerosis|August 1, 1995
Long-term efficacy and tolerability of simvastatin in a large cohort of elderly hypercholesterolemic patientsP J Lansberg, Y B Mitchel, D Shapiro, et al.
Annales De Genetique|January 1, 1992
Genetic epidemiology of lipoprotein lipase deficiency in Saguenay-Lac-St-Jean (Québec, Canada)C Dionne, C Gagné, P Julien, et al.
Arteriosclerosis and Thrombosis : a Journal of Vascular Biology|July 11, 1992
In vivo metabolism of apolipoprotein A-I in a patient with homozygous familial hypercholesterolemiaJ R Schaefer, D J Rader, K Ikewaki, et al.
The American Journal of Cardiology|February 15, 1994
Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemiaJ Davignon, G Roederer, M Montigny, et al.
Free Radical Biology & Medicine|September 18, 1999
Oxidative damage and protection by antioxidants in the frontal cortex of Alzheimer's disease is related to the apolipoprotein E genotypeC Ramassamy, D Averill, U Beffert, et al.
Journal of Internal Medicine|February 20, 2007
Biochemical and bioimaging markers for risk assessment and diagnosis in major cardiovascular diseases: a road to integration of complementary diagnostic toolsS M Marcovina, F Crea, J Davignon, et al.
The Journal of Clinical Investigation|March 1, 1995
The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humansD J Rader, W A Mann, W Cain, et al.
Atherosclerosis|June 28, 2001
Efficacy and short-term safety of a new ACAT inhibitor, avasimibe, on lipids, lipoproteins, and apolipoproteins, in patients with combined hyperlipidemiaW Insull, M Koren, J Davignon, et al.
Pageof 24